[HTML][HTML] Posters from the Canadian Society of Respiratory Therapists 2020 E-Conference Series

NONIHF OSCILLATORY - Can J Respir Ther Vol - ncbi.nlm.nih.gov
… the links as both topics are extremely interesting to me at this time. As a respiratory therapist,
my … Mechanically ventilated adults from three centers admitted to the ICU who were deemed …

Which Patients With Asthma in the Emergency Department Need to Be Admitted to the Hospital?

JE Bennett, AS Chidekel - Curbside Consultation in Pediatric …, 2024 - taylorfrancis.com
… for more aggressive therapy and monitoring. Those patients … therapy as outlined in Questions
27 and 33 are candidates for discharge home on medical grounds. Children should show

[HTML][HTML] Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label …

LM Yu, M Bafadhel, J Dorward, G Hayward, BR Saville… - The Lancet, 2021 - thelancet.com
… from inhaled budesonide for COVID-19 in patients not admitted to … effective and safe
community-based treatments for COVID-19, … PCR testing, but capacity issues early in the …

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind …

LA Lee, Z Bailes, N Barnes, LP Boulet… - … Lancet Respiratory …, 2021 - thelancet.com
… the most appropriate inhaled treatment on the basis of patients' clinical problems being
addressed, … in the past year requiring oral corticosteroids or admission to hospital, or both. Mean …

[HTML][HTML] COVID-19 pandemic and non invasive respiratory management: every Goliath needs a David. An evidence based evaluation of problems

JC Winck, N Ambrosino - Pulmonology, 2020 - Elsevier
… Although there is a role for non-invasive respiratory therapies in the context of COVID-19
ARF, … Indirectly, non invasive respiratory therapies may be of particular benefit in reducing the …

[HTML][HTML] Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

S Ramakrishnan, DV Nicolau, B Langford… - … Lancet Respiratory …, 2021 - thelancet.com
cases were severe and would require hospitalisation. Using 80% power at 0·05 level, we
required 199 patients in each group to show … they were directly admitted to the respiratory high …

Respiratory support for adult patients with COVID‐19

JS Whittle, I Pavlov, AD Sacchetti… - Journal of the …, 2020 - Wiley Online Library
… severe or critical cases. In Italy, the number of critically ill COVID-19 … , mechanical ventilation,
and ICU admission in some severely ill … with the use of any particular respiratory treatment. …

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 …

PD Monk, RJ Marsden, VJ Tear, J Brookes… - … Lancet Respiratory …, 2021 - thelancet.com
… safety of inhaled nebulised interferon beta-1a (SNG001) for the treatment of patients admitted
to … We aimed to evaluate the potential effects of an inhaled interferon beta-1a formulation (…

Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection

CC Gómez, ÓP Rodríguez, ML Torné… - Medicina Intensiva …, 2020 - Elsevier
… 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated
by the acute … At present, the respiratory therapies that define NIRS and HFNC and NIMV. …

Therapeutic potential of ciclesonide inhalation for COVID-19 pneumonia: report of three cases

K Iwabuchi, K Yoshie, Y Kurakami, K Takahashi… - Journal of infection and …, 2020 - Elsevier
… three cases of the COVID-19 pneumonia successfully treated with ciclesonide inhalation. …
Due to anti-nuclear antibody (discrete type) 1280x at blood collection on admission, and poor …